AA
EW icon

Ancora Advisors’s Edwards Lifesciences EW Stock Holding History

Ancora Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.7K Buy
621
+282
+83% +$23.2K ﹤0.01% 1142
2025
Q4 		$28.9K Buy
339
+291
+606% +$23.9K ﹤0.01% 1374
2025
Q3 		$3.73K Hold
48
– – ﹤0.01% 1553
2025
Q2 		$3.75K Sell
48
-17
-26% -$1.27K ﹤0.01% 1535
2025
Q1 		$4.75K Sell
65
-46
-41% -$3.29K ﹤0.01% 1435
2024
Q4 		$8.25K Buy
111
+46
+71% +$3.22K ﹤0.01% 1372
2024
Q3 		$4.32K Buy
65
+3
+5% +$218 ﹤0.01% 1467
2024
Q2 		$5.77K Hold
62
– – ﹤0.01% 1412
2024
Q1 		$5.97K Hold
62
– – ﹤0.01% 1420
2023
Q4 		$4.76K Sell
62
-290
-82% -$20.2K ﹤0.01% 1397
2023
Q3 		$24.4K Buy
352
+290
+468% +$23.3K ﹤0.01% 1095
2023
Q2 		$5.89K Buy
62
+17
+38% +$1.48K ﹤0.01% 1360
2023
Q1 		$3.72K Hold
45
– – ﹤0.01% 1445
2022
Q4 		$3K Hold
45
– – ﹤0.01% 1540
2022
Q3 		$4K Hold
45
– – ﹤0.01% 1679
2022
Q2 		$4K Hold
45
– – ﹤0.01% 1794
2022
Q1 		$5K Sell
45
-6
-12% -$673 ﹤0.01% 1945
2021
Q4 		$7K Buy
+51
New +$5.95K ﹤0.01% 1927
2021
Q3 		– Sell
-51
Closed -$5K – 2234
2021
Q2 		$5K Buy
+51
New +$4.81K ﹤0.01% 1687
2021
Q1 		– Sell
-105
Closed -$10K – 1755
2020
Q4 		$10K Buy
105
+50
+91% +$4.15K ﹤0.01% 1197
2020
Q3 		$4K Buy
+55
New +$4.29K ﹤0.01% 1260
2018
Q4 		– Sell
-72
Closed -$4K – 787
2018
Q3 		$4K Buy
+72
New +$3.52K ﹤0.01% 1264
2017
Q1 		– Sell
-1,851
Closed -$58K – 751
2016
Q4 		$58K Buy
+1,851
New +$60K ﹤0.01% 751

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ancora Advisors's EW Position: Q1 2026 in Review

Ancora Advisors increased its Edwards Lifesciences (EW) stake by 83% in Q1 2026, buying an estimated $23.2K and bringing the position to 621 shares worth $49.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Ancora Advisors first reported a position in EW in Q4 2016 and has held it in 23 quarters since. The position peaked at $58K in Q4 2016. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Ancora Advisors held 621 shares of Edwards Lifesciences worth $49.7K as of Q1 2026.
  • Ancora Advisors bought 282 Edwards Lifesciences shares in Q1 2026, an estimated $23.2K.
  • Edwards Lifesciences made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1142 holding.
  • Ancora Advisors first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 23 quarters since.
  • Ancora Advisors's Edwards Lifesciences position peaked at $58K in Q4 2016.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.